Calysta
PrivateLast Round
Series D
Extension
Sep 9, 2021
Total Funding Raised
$153.8M
Company Overview
Calysta is a biotechnology company that develops and commercializes sustainable, fermentation-based protein ingredients for the aquaculture, livestock, and pet food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Calysta Comparables
Compare Calysta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeNova | 85% | |
| Unibio | 84% | |
| String Bio | 80% | |
Calysta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Sep 9, 2021 | ||||
| Series D | Jun 27, 2019 | ||||
| Series D | May 1, 2017 | ||||
| Series C | Feb 2, 2016 | ||||
| Grant | Jan 12, 2016 | ||||
Series B | Jan 22, 2015 |
Key People
Founding team and executive leadership
Calysta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Municipal Employees' Retirement System of Michigan | Series D, Series C |
| Temasek | Series D |
| UK government | Grant |
| Aqua-Spark | Series B, Series C, Series D, Series D Extension |
| Baruch Future Ventures | Series D |
| Bessemer Trust | Series C |
| Walden International | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
R&D labs and pilot plants in the US and UK have been closed.
- Feb 27, 2025
Launched first dog food with FeedKind Pet protein in partnership with Marsapet.
Calysta Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Calysta's valuation, stock price, and market status.